Skinvisible SKVI
OTC SKVI
$0.20 -0.23 (-53.49%)
At close: Sep 4, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Total Current Liabilities (2010 - 2026)

Skinvisible's (SKVI) quarterly Total Current Liabilities came in at $5.5 million in Q2 2026, up 22.35% year-over-year from $4.5 million in Q2 2025, and up 4.92% quarter-over-quarter from $5.3 million in Q1 2026.

Analysis

Skinvisible (SKVI) Total Current Liabilities (2010 - 2026) Analysis & Trends

Skinvisible has disclosed Total Current Liabilities across 17 years of filings, most recently posting $5.5 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 22.35% year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (up 22.35% YoY), while the FY2025 annual figure was $5.0 million, up 37.2% from the prior year.
  • Total Current Liabilities came in at $5.5 million for Q2 2026 at Skinvisible, up from $5.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $5.5 million in Q2 2026 to a low of $2.7 million in Q1 2023.
  • Average Total Current Liabilities over 5 years is $4.0 million, with a median of $3.8 million recorded in 2024.
  • Year-over-year, Total Current Liabilities declined 12.62% in 2023 and soared 50.18% in 2024.
  • Over 5 years, Total Current Liabilities stood at $3.6 million in 2022, then retreated by 3.64% to $3.5 million in 2023, then advanced by 4.12% to $3.7 million in 2024, then soared by 37.2% to $5.0 million in 2025, then gained by 10.33% to $5.5 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $5.5 million in Q2 2026, $5.3 million in Q1 2026, and $5.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 54.90 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 41.64 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 31.75 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 32.65 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 37.11 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 354.06 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 1.31 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 607.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 5.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.54 Mn
Mar 31, 2026 5.28 Mn
Dec 31, 2025 5.02 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 4.53 Mn
Mar 31, 2025 4.26 Mn
Dec 31, 2024 3.66 Mn
Sep 30, 2024 4.64 Mn
Jun 30, 2024 4.02 Mn
Mar 31, 2024 4.09 Mn
Dec 31, 2023 3.51 Mn
Sep 30, 2023 3.24 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 2.73 Mn
Dec 31, 2022 3.64 Mn
Sep 30, 2022 3.62 Mn
Jun 30, 2022 3.41 Mn
Mar 31, 2022 3.07 Mn
Dec 31, 2021 3.06 Mn
Sep 30, 2021 3.11 Mn